IceCure Medical Expands ChoICE Study for Breast Cancer
Caesarea, Israel, August 7, 2026 IceCure Medical has announced a significant expansion of its U.S. post-marketing clinical program with...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Caesarea, Israel, August 7, 2026 IceCure Medical has announced a significant expansion of its U.S. post-marketing clinical program with...
Nantong, China, August 7, 2026 Ractigen Therapeutics has announced a significant milestone in the development of its investigational RNA...
Nutley, New Jersey, USA, August 5, 2026 Reckitt has received U.S. Food and Drug Administration (FDA) approval for Mucinex®...
Galway, Ireland, August 6, 2026 Medtronic has secured an expanded CE Mark indication for its Afferaâ„¢ Mapping and Ablation...
MADRID, Spain, April 2026 Corify Care has achieved a major regulatory milestone with U.S. FDA 510(k) clearance for its...
Madrid | January 28, 2026 — Corify Care, a cardiovascular MedTech innovator, announced a major advancement in cardiac electrophysiology...
